Oral Thin Films Market: Introduction

 

According to the report, the global oral thin films market was valued at US$ 2.6 Bn in 2019. It is projected to expand at a CAGR of ~9% from 2020 to 2030. Oral thin film drug is a promising drug delivery dosage form, which delivers drugs by adhering to the oral mucosa. Rise in demand for thin film drug delivery systems, considerable research & development, and strategic alliances between novel technology owners and large pharmaceutical companies are major factors that are anticipated to drive the global oral thin films market during the forecast period. North America held a major share of the global oral thin films market in 2019, due to higher penetration of the oral thin film technology and increase in focus on new product launches by industry players in the region.

 

The oral thin films market in Europe is expected to expand at a high CAGR of 11.2% from 2020 to 2030, due to increase in the number of geriatric patients suffering from dysphagia and rise in oral thin film introductions in the region.

 

Request a Sample of Oral Thin Films Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84269

 

Rising Demand for Thin Film Drug Delivery System to Drive Market

 

The demand for thin film drug delivery system is rising due to benefits such as larger surface area, precision medication, and pleasant color & flavor over traditional drug delivery systems. Thin film drugs are reported to be the preferred choice of patients as well as medical practitioners, as they are more patient-friendly and offer good quality results. Oral thin film drugs offer high compliance to patients, and ease of storage and transportation. Moreover, these offer precise and accurate dosing with the desired effective outcome. Hence, the thin film drug delivery system market has recorded substantial attractiveness. High acceptance level and impressive advantages have further propelled the global oral thin film market.

 

Enquiry before Buying Oral Thin Films Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84269

 

Sublingual Films Dominated Global Market

 

In terms of product, the global oral thin films market has been classified into sublingual film, fast dissolving oral film, and buccal film. The sublingual film segment dominated the global oral thin films market in 2019, and the trend is projected to continue during the forecast period. Significant research activities, strong product pipeline, and high market adoption of sublingual film are expected to boost the segment during the forecast period.

 

High Prevalence of Neurological Disorders to Drive Global Market

 

In terms of indication, the global oral thin films market has been categorized into pain management, neurological disorders, nausea & vomiting, opioid dependence, and others. The neurological disorders segment held a major share of the global oral thin films market in 2019. Rise in prevalence of neurological disorders is expected to drive the segment during the forecast period. According to the data published by the National Center for Biotechnology Information, the mean prevalence of neurological disorders was around 2,394 per 100,000 populations in India.

 

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42869

 

Retail Pharmacies to be Major Distribution Channel

 

Based on distribution channel, the global oral thin films market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the market in 2019, owing to higher preference for retail pharmacies among end users, easy availability of a wide range of products, and increase in the number of retail pharmacies in developing countries.

 

North America to Dominate Global Market; Europe to Offer Significant Opportunities

 

In terms of region, the global oral thin films market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a leading share of the global oral thin films market during the forecast period. Higher penetration of oral thin films, availability of the products, and presence of a large number of suppliers compared to other regions are the major factors driving the market in the region. The market in Asia Pacific is expected to expand at a high CAGR in the near future, owing to the presence of local as well as global players and an increase in the demand for oral thin films in the region. The oral thin films market in Europe is likely to expand at a rapid pace in the near future. Japan and China are anticipated to be lucrative markets for oral thin films during the forecast period. Presence of large geriatric patient population with dysphagia and increase in healthcare expenditure in these countries are projected to propel the market in Asia Pacific over the next few years.

 

Request for Analysis of COVID19 Impact on Oral Thin Films Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=42869

 

Growth Strategies of Key Market Players

 

Key players operating in the global oral thin films market are ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt. Ltd., Shilpa Therapeutics Pvt. Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceutical, IntelGenx Corp., Dr. Reddy's Laboratories, Kyu Pharmaceutical Co Ltd, Seoul PharmaCo, and C.L. Pharm. These companies engage in research & development to develop novel products in order to expand product offerings and customer base. In January 2021, Cure Pharmaceutical received the U.S. FDA approval for CUREfilm Blue for the treatment of erectile dysfunction (ED). It increased the commercial opportunity for Cure Pharmaceutical in the U.S.

 

More Trending Reports by Transparency Market Research:

 

Telemedicine Market Telemedicine has evolved gradually with the rise of the Internet age. The ubiquity of smart devices that feature high-quality video transmission has opened up the possibilities of delivering remote healthcare to patients at their convenient locations. Thus, telemedicine is emerging as an alternative for in-person visits for primary as well as specialty care.

 

Life Sciences BPO Market In the life sciences BPO market, blockchain and serialization technologies are facing the challenges of counterfeit pharmaceuticals. In addition to providing a clearer and better perspective of clinical findings, virtual trials and data management are speeding up the decision making process. Investments in personalized medications and specialist therapies are gaining popularity.

 

Unfractionated Heparin Market Due to its numerous benefits, unfractionated heparin is gaining popularity. It is generally recognized due to its reversibility (protamine), short half-life, immediate beginning of action, and simple laboratory monitoring. Moreover, it is cost-effective. Unfractionated heparin is also used in the treatment of VTE, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). 

 

About Us Section:

 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse informationNow avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

 

Contact Us

 

Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/